financetom
Business
financetom
/
Business
/
Inspiration4: Meet members of SpaceX’s first 'all-civilian' mission
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Inspiration4: Meet members of SpaceX’s first 'all-civilian' mission
Sep 13, 2021 9:17 AM

Two days from now, Elon Musk’s SpaceX will launch its "first all-civilian (and privately financed) trip to orbit." A four-member non-professional crew of astronauts will be part of SpaceX’s three-day Inspiration4 mission.

The Inspiration4 astronauts will be launched on a Falcon 9 rocket from Nasa's Kennedy Space Centre in Florida on September 15 at 8 pm Eastern Daylight Time (EDT).

The crew, which has been training together for several months, will comprise a billionaire, a geoscientist, a bone cancer survivor and a data engineer, according to Space.com.

Here’s a look at the crew:

Jared Isaacman

The 34-year-old billionaire and founder of Shift4 payments service will command the Inspiration4 flight. Isaacman pursued his dream of flying in various ways. According to space.com, he bought all the seats on the SpaceX flight for an undisclosed price. He has over 6,000 hours of flight aircraft experience, having circumnavigated the world and flown in multiple air shows. He took over Draken International, a jet pilot training company.

Sian Proctor

The 51-year-old geoscience professor will be the first person from Guam to fly into space. She was selected as part of a competition organised by Isaacman. Proctor won that competition by raising awareness about women of colour in the space industry. She has also received training in flying fighter aircraft similar to MiG-29 and is a pilot of a Cessna 172 aircraft.

Hayley Arceneaux

The 29-year-old is a physician at St Jude Children’s research hospital. Isaacman has donated $100 million to the hospital, for which he hopes to raise another $100 million through his space mission. She comes from a family of aerospace engineers. Arceneaux is a bone cancer survivor, and is fitted with a prosthetic. She will be the crew's medical officer during the flight.

Chris Sembroski

The 41-year-old data engineer and former US space camp counsellor has served in the US Air Force and had been posted in Iraq. He now works at Lockheed Martin. He got his seat on the space flight after the winner of a competition to raise funds for St Jude Children’s research hospital passed on his ticket to Sembroski.

Also read: Can marketers conquer Space?

(Edited by : Shoma Bhattacharjee)

First Published:Sept 13, 2021 6:17 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hims & Hers to Keep Offering Weight-Loss Shots After Novo Nordisk Partnership Termination, CEO Says
Hims & Hers to Keep Offering Weight-Loss Shots After Novo Nordisk Partnership Termination, CEO Says
Jun 25, 2025
08:08 AM EDT, 06/25/2025 (MT Newswires) -- Hims & Hers Health ( HIMS ) will continue offering low-cost weight-loss injections despite Novo Nordisk's ( NVO ) decision to terminate their distribution partnership, Bloomberg reported Tuesday, citing CEO Andrew Dudum. We're upset that Novo is feeling the pressure and not comfortable, Dudum said but there's just no way in hell we're...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Plus Therapeutics Says FDA Clears Reyobiq IND Application for Pediatric Brain Cancer; Shares Up Pre-Bell
Plus Therapeutics Says FDA Clears Reyobiq IND Application for Pediatric Brain Cancer; Shares Up Pre-Bell
Jun 25, 2025
08:06 AM EDT, 06/25/2025 (MT Newswires) -- Plus Therapeutics ( PSTV ) said Wednesday that the US Food and Drug Administration has cleared its investigational new drug application for Reyobiq, paving the way for a phase 1/2a trial targeting pediatric patients with recurrent or progressive high-grade glioma and ependymoma. The company said the trial, which will assess safety, maximum tolerated...
Arbutus Biopharma Reacquires Rights to Imdusiran in China
Arbutus Biopharma Reacquires Rights to Imdusiran in China
Jun 25, 2025
08:08 AM EDT, 06/25/2025 (MT Newswires) -- Arbutus Biopharma ( ABUS ) said Wednesday that it has reacquired rights to its lead compound, imdusiran, in Greater China from Qilu Pharmaceutical. Arbutus said the parties have mutually agreed to end their partnership, which began in 2021, to develop, manufacture and commercialize imdusiran in mainland China and other Asian markets. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved